High folate intake has been suggested as an important factor in cancer prevention; however, previous studies on the relation among folate intake, serum folate, and plasma homocysteine (hcy) are controversial. We conducted a hospitalbased, case-control study in Brazil investigating associations between dietary and circulating vitamins B-6 and B-12 and folate, hcy, genotypes of folate-metabolizing enzyme methylenetetrahydrofolate reductase (MTHFR C677T, A1298C), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR A2756G), methionine synthase reductase (MTRR A66G), and reduced folate carrier (RFC1 G80A) and risk of cervical intraepithelial neoplasia (CIN) grades 1 (CIN1), 2 (CIN2), and 3 (CIN3). The study was composed by 453 controls, 140 CIN1, 126 CIN2, and 231 CIN3. We investigated the joint effects of genetic variants of folate-related genes using genetic risk scores (GRSs) by summing the number of risk alleles for CIN1 and CIN2+ (CIN2 and CIN3 cases). The OR (95% CI) for CIN1 and CIN2+ per each risk allele were 1.29 (1.01, 1.65) and 1.22
Introduction
Cervical cancer is one of the 3 most common cancers among women worldwide, with about half a million cases diagnosed and around one-quarter of a million deaths estimated in 2008 (1) . More than 85% of these cases and deaths are observed in lowresource regions in sub-Saharan Africa, south central Asia, and Latin America (1, 2) . Infection with oncogenic human papillomavirus (HPV) 9 types is the central risk factor for cervical cancer, but other factors modulate infection and lesion risk: tobacco smoking, long-term oral contraceptive use, and high parity (2-6). Longterm, persistent, oncogenic HPV infection causes precancerous lesions, the cervical intraepithelial neoplasia (CIN), progressing from less severe CIN grade 1 (CIN1) through grade 2 and grade 3 (CIN2+) toward invasive cancer.
Dietary intake of folate and the coenzyme vitamins B-6 and B-12 has been investigated as having an important role in the prevention of cancer for: 1) synthesis of methionine from homocysteine (hcy) for methylation of DNA to guarantee genomic stability and gene expression; and 2) synthesis of thymidylate and purine precursors of DNA and RNA (7) . However, no evidence for an association was observed from the majority of studies of folate intake and precancerous cervical lesions or cancer (8) (9) (10) (11) , except for 2 studies that showed an ;60% reduction in risk of precancerous lesions for intakes >400 mg/d (12, 13) . Previous studies suggested that serum folate is not associated with CIN or cancer after adjusting for confounding variables (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Only 1 of 4 studies of RBC folate concentrations showed a negative association with CIN (18, 21, 24, 25) and no association was observed for tissue folate (16) . On the other hand, the majority of studies using hcy reported a positive association after adjustment for confounders (14, (19) (20) (21) (22) . Although hcy has been considered a surrogate measure with low specificity, it is an indirect marker of folate status (26) .
The most commonly studied polymorphism of an enzyme involved in folate metabolism with respect to cervical cancer risk is the mutation in the methylenetetrahydrofolate reductase (MTHFR) enzyme gene (677C/T, 1298 A/C) associated with reduced plasma folate concentrations. The MTHFR accelerates the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the circulating and physiologically active form of folate, which is necessary for the conversion of hcy to methionine in a vitamin B-12-dependent reaction and catalyzed by methionine synthase reductase (MTRR) (identified mutation is 66 A/G) and 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR) (identified mutation is 2756 A/G). Homozygous individuals for the less frequent variant (TT) of MTHFR677 presented only one-third of the expected enzyme activity (27) . In addition to MTHFR and MTRR, the reduced folate carrier (RFC1) (80 G/A), which transports plasma folate into the cells, was associated with gastroesophageal cancer (28) . Examining the relation between folate intake and cancer risk according to the genotype of the folate-related enzyme is particularly important. Only 2 studies have examined the influence of MTHFR polymorphism and folate status and found a higher risk of CIN2+ with lower intake or circulating folate among carriers of a mutant variant for MTHFR (677C/T) (8, 23) .
In the present study, we investigated the association of folate and coenzyme vitamins B-6 and B-12 of folate metabolism, hcy, and the joint effect with polymorphisms in genes involved in these cycles with the risk of cervical neoplasia in a hospitalbased, case-control study conducted in Brazil.
Participants and Methods
Participants and study design. Participants in this study were selected from the Brazilian Investigation into Nutrition and Cervical Cancer Prevention (BRINCA) Study. The Institutional Ethics Committee at the School of Public Health, University of Sã o Paulo, Brazil (1031 Brazil ( /2003 approved the study protocol and written informed consent was obtained from all participants. The BRINCA Study included women attending cervical cytological screening at 2 major public hospitals for cancer screening and treatment: Instituto Brasileiro de Controle do Câ ncer and Hospital Perola Byington in Sã o Paulo, Brazil. We prospectively enrolled women selected at the same time from among those attending routine gynecological screening or those referred for cytology confirmation. Eligible women were Sã o Paulo residents aged 21-65 y and had no prior hysterectomy, no previous treatment for CIN, and no cancer history. Women who were positive for HIV or who had been pregnant or breastfeeding within 6 mo of enrollment were ineligible.
In the BRINCA Study, eligible women were invited and interviewed prior to returning to the doctor for cytological diagnosis, which was obtained within 2 wk after enrollment in the study. Cases included women with a histological diagnosis of CIN1, CIN2, or CIN3 or invasive adenocarcinoma, adenosquamous, or squamous cell carcinoma of the cervix that were reviewed by 2 pathologists. During the same period, control women were selected in the same clinics where cases were diagnosed. To be eligible, control women had to have a cytological diagnosis within normal limits in addition to meeting the above criteria for cases.
Sampling strategies, participation rates, and initial results were reported elsewhere (29) . A total of 1729 women were contacted between 2003 and 2005. Fifty-three (3.1%) refused participation (34 potential cases and 19 potential controls) and 1676 women were interviewed; of these, 1394 (83.2%) completed the study protocol. Among those enrolled, 1179 women were eligible for the BRINCA Study; of these, 121 participants were excluded because of incomplete nutritional data. For the present analysis, invasive cancer cases (n = 108) were not considered because of the possible effects of the disease process on the nutritional measurements. Overall, 453 controls and 3 case groups were included: 140 CIN1, 126 CIN2, and 231 CIN3.
Data collection. Participants underwent a personal interview by trained dietitians who were unaware of the group assignment. A standardized questionnaire was used to elicit information on socioeconomic and demographic characteristics, tobacco use, alcohol consumption, reproductive and sexual histories, and other risk factors for cervical neoplasia. Self-reported ethnicity/race was defined in 5 categories: white, black, yellow, mulatto, or Indian. BMI was expressed as kg/m 2 and based on weight and height measurements with participants wearing light clothes and no shoes (30) .
Dietary assessment. Food consumption was assessed using a previously validated FFQ (31) . In summary, we conducted a validation study in a random subsample of 96 cases and controls from the BRINCA Study using three 24-h dietary recalls obtained during a year reported in a second FFQ. The energy-adjusted, intra-class correlations between 2 FFQs (1-y interval) ranged from 0.4-0.6 (B vitamins, iron, zinc, magnesium, phosphorous, and calcium) to 0.7 (vitamin A and folate). The energy-adjusted and deattenuated Pearson correlations (R) between FFQ and dietary recall ranged from r = 0.3-0.4 (macronutrients) to 0.5-0.8 (fiber, vitamin A, calcium, folate, and phosphorous). Women were asked about the usual frequency of consumption of 76 foods items and the portion sizes, an open-ended food section, and vitamin and mineral supplements consumed during the previous year. Nutrient and food groups were analyzed using the Dietsys software version 4.01 (32) Serum micronutrient analyses. All participants were scheduled to provide a fasting blood sample within 1 wk after recruitment. Whole blood was protected from light, centrifuged within 1 h of collection, and frozen at 270°C until analysis. Serum folate and vitamin B-12 concentrations were measured using a commercial fluoroimmunoassay kit (PerkinElmer, Wallac Oy). Plasma (EDTA) Hcy values were measured by HPLC with fluorimetric detection and isocratic elution (33) . Serum vitamin B-6 was quantified using HPLC with UV detection and isocratic elution (34) . Instrumentation used for HPLC was a Shimadzu LC10AD (Shimadzu).
All samples were analyzed within 6 mo after collection. The laboratory assayed internal and external blinded quality control specimens in each run. From the control specimens, the accuracy and interassay CVs for these analytes were within 7%.
HPV testing. Exfoliated ectocervical and endocervical cells were collected using the DNA-Cytoliq (Digene Brazil) liquid-based system. Samples were collected using the brush provided with the kits and immersed in Universal Collecting Medium vials. The cervical specimen was stored at 4°C until processing for cytology and HPV testing.
Cervical specimens were centrifuged at 1957 3 g for 10 min at 22-24°C. Cells were digested with 0.2 g/L proteinase K in 50 mL 100 mmol/L NaCl, 10 mmol/L Tris-HCl pH 8.0, 25 mmol/L EDTA buffer pH 8.0, 0.5% SDS between 2 to 16 h at 60°C, and purified. Extracted DNA was tested for the presence of human DNA using a PCR protocol for b-globin and for HPV DNA by a PCR protocol amplifying a highly conserved, 450-bp segment in the L1 viral gene (flanked by primers MY09/11), as previously described (29) .
HPV types were classified as having either high-risk oncogenic potential or low-risk oncogenic potential. High-risk types included HPVs 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 (35) . HPV infection status was classified as per the following 4 hierarchical mutually exclusive categories: 1) HPV negative; 2) only positive for low-risk HPV types; 3) positive for at least one high-risk HPV type except HPV-16 and HPV-18; and 4) positive for HPV-16 and/or HPV-18.
Genotyping. The genotyping of the single nucleotide polymorphisms (SNPs) for MTHFR 677C/T (rs1801133) and 1298A/C (rs1801131), MTR 2756A/G (rs1805087), MTRR 66 A/G (rs1801394), and RFC1 80G/A (rs1051266) polymorphisms was performed without knowledge of the disease status using an allele-specific PCR with molecular beacons assay (36) and was performed under contract by Prevention Genetics. Names, primers, and conditions of the markers used are available in Supplemental Table 1 . The homogeneous assay used 2-tailed allele-specific primers, a common reverse primer, and 2 different, fluorescently labeled, universal primers in a single well reaction. Submicroliter PCR reactions were carried out with Array Tape instrumentation, and allele calls were generated based on clustering of fluorescent signals (37) . The internal quality of genotype data was assessed by typing 10% of blinded samples in duplicate; the resulting concordance was >99%.
Samples for SNPs genotyping were not available for 143 controls, 9 diagnosed with CIN1, 38 diagnosed with CIN2, and 61 diagnosed with CIN3 because of a limited sample volume.
Allelic and genotype frequencies for each SNP were calculated from the Hardy-Weinberg equilibrium (P > 0.05) using an online tool (38) .
Variables. Concentrations of folate, vitamin B-6 and B-12, hcy, and dietary nutrients were categorized into 2 groups (higher or lower than the median value) based on the distribution among controls. Other continuous cofactors, except age, were categorized into tertiles or quartiles based on the distribution among controls. Age was divided into categories with cutoffs at decades of year (21-65 y). Race/ethnicity was categorized as white and non-white (black women, mulatto, yellow, and Indian). Classification of socioeconomic status was based on income per person per month ($100, 51-99, #50 US$). Educational level was divided into 3 categories ($11, 6-10, #5 y). Participants were distributed into 6 categories of smoking status and cumulative effects of tobacco consumption using pack-year, equivalent to one pack of daily cigarette smoking during 1 y: 1) nonsmoker; 2) former smoker #5.80 pack-year (median value); 3) former smoker $5.81 pack-year; 4) current smoker #4.80 pack-year; 5) current smoker 4.81-14.0 pack-year; and 6) current smoker >14.0 pack-year. The participant characteristics according to sexual and reproductive history were categorized as: age at first vaginal intercourse into 4 groups ($21, 19-20, 16-18, #15 y), lifetime number of sexual partners into 3 categories (1, 2-3, $4), and parity divided into 5 categories (never, 1, 2, 3, $4).
Statistical analysis. Median values and IQRs were calculated for micronutrient concentrations, dietary intake, and continuous covariates according to outcome status. Pearson x 2 tests were used to examine differences in proportions and the Mann-Whitney test for differences in continuous variables between groups compared with controls. Dietary nutrient intakes were adjusted for total energy by the residual method (39) . Because of a similarity in the exposure of interest between CIN2 and CIN3 (P > 0.05, Mann-Whitney test) and the disease stages toward cervical cancer, we combined CIN2 and CIN 3 cases in one case group (CIN2+).
A genetic risk score (GRS) was developed with the folate-related genes associated with P value # 0.15 for CIN1 or CIN2+. Coding values were 0 for the lowest risk allele, +1 for the heterozygote, and +2 for the
Separate unconditional logistic regression models were used to calculate ORs and 95% CIs for 2 outcomes (CIN1 and CIN2+) with individuals in the lowest risk of the exposure of interest as reference. All analyses were adjusted for age, hospital, race/ethnicity, education, and potential confounders (smoking, sexual debut, lifetime sexual partner, and parity) or mediators (HPV status) if the inclusion in any of the models caused a change in the OR estimate of $10%. Tests for linear trend were calculated by assigning the median value for each exposure category and modeling the values as a continuous variable.
To investigate possible interactions, dietary intake or micronutrient concentrations were stratified by GRS (higher or lower than median score). Interaction was identified by comparing the observed OR with dietary intake or nutrient concentration (higher or lower than the median intake or circulating concentration) and GRS with the expected OR using a simple mathematical operation (40) . For statistical interaction, the Wald test and likelihood ratio test were used to test for significance of the estimated interaction term (41, 42) . In the likelihood ratio test, the difference of log likelihood statistics for 2 models (one model with and another model without interaction terms), and in the Wald test only one variable, the interaction term, was tested (41, 43) .
Significance was set at 0.05 and OR with 95% CI is presented. All P values were derived from 2-sided statistical tests. All analyses were done in STATA 10.0 (Statacorp).
Results
Differences were observed between cases and controls: cases were significantly younger, were non-white, less educated, had lower income, were smokers, reported early sexual debut, had a higher number of pregnancies, and presented with lower BMI compared with controls. The percentage of HPV infection by oncogenic type was higher among cases ( Table 1) .
Dietary intake of folate and vitamins B-6 and B-12 did not differ according to study groups (Table 1) . Dietary intake of folate was extremely low: only 11.0% of the study population reached the Estimated Average Requirements for folate (320 mg/d) and 4.2% reached the Recommended Dietary Allowances (400 mg/d) (44). Higher intakes of alcohol were observed among women diagnosed with CIN1 and CIN3. Total energy intake was higher among CIN3 cases and consumption of dark green and deep yellow vegetables and fruit was significantly lower among CIN1 and CIN3 cases compared with controls.
Blood samples were drawn from 74% of controls and 79% of cases. Serum concentrations of folate were significantly lower among controls compared with cases (Table 1) . Plasma values of hcy were higher with lower serum concentrations of vitamin B-6 among CIN2+ cases. Folate and hcy concentrations increased from controls through CIN1, CIN2, and CIN3 cases. Folate deficiency (serum folate <6.795 nmol/L) was observed in 8% of controls and in 2, 2, and 4% of CIN1, CIN2, and CIN3 cases, respectively. Vitamin B-6 deficiency (serum vitamin B-6 <20 nmol/L) was observed in 52% of controls and in 55, 68, and 61% of CIN1, CIN2, and CIN3 cases, respectively. Vitamin B-12 deficiency (serum vitamin B-12 <0.148 nmol/L) was observed among 14.5% of controls and 17, 18, and 12% of CIN1, CIN2, and CIN3 cases, respectively (data not shown).
The allele distributions of folate-related genes are presented in Table 2 . Based on the estimated risk of CIN1 and CIN2+, we established the increased risk allele: wild alleles for MTHFR C677T, A1298C, and RFC1 G80A and mutant allele for MTR A2756G. The GRS was created to assess the joint effects of SNPs for CIN1 and CIN2+ risk. Among the 5 SNPs, we found significant associations with CIN1 for MTHFR C677T and RFC1 G80A and with CIN2+ for MTHFR C677T, A1298C, and MTR A2756G ( Table 3) . Each risk allele (1 point) was associated with an ;35% increased risk of CIN1. For CIN2+, each risk allele was associated with a 22% increased risk; however, there was no significance after adjustment HPV infection.
Although total folate intake was not associated with cervical dysplasia, in stratified analysis according to median values of GRS, increased risk of CIN2+ was observed among women with dietary folate lower than the median intake and GRS $4 compared with participants with higher folate intake and GRS #3 (reference group); however, after adjustment for confounding variables, no association was observed ( Table 4) . By comparing the groups with higher than median concentrations of circulating nutrients and GRS #3 (reference group) with the group with lower concentrations of serum vitamin B-6 and GRS $4, an increased risk of CIN2+ was observed, even after adjusting for confounding variables and HPV infection. However, the interaction was not significant (P = 0.89 for Wald test and P = 0.76 for likelihood ratio test; data not shown). For serum folate, women with lower than the median concentrations with higher GRS had a decreased risk of CIN1 and CIN2+ after multiple adjustment (Table 4) 
Discussion
In our study, a significant association with cervical neoplasia was observed among women reporting lower folate intake and carrying more than 4 risk alleles. Conversely, higher intake of vitamin B-6 was negatively associated with advanced cervical dysplasia, with a linear trend according to the presence of the mutant allele. 2010 Tomita et al.
To our knowledge, this is the first study investigating the joint effect of diet, circulating micronutrients, and folate pathway polymorphisms, other than those in MTHFR, in a relatively large group of patients and risk of precancerous cervical lesions and cancer. The study assessed 5 polymorphisms with cofactors involved in many cycles of folate metabolism, incident cases of CIN1 and CIN2+, assessment of habitual dietary intake, and blood collection reflecting recent intake of folate and hcy, a sensitive inverse indicator of folate status. Participants were invited and interviewed prior to returning to the doctor for diagnosis and therefore had no reason to modify the diet; thus, we think that recall bias was spared. Unfortunately, examination of several gene-gene interactions of both genes with a homozygous mutant allele was not possible, which is recognized as an exceedingly rare event in the population (45) . We also tested the interaction of combined heterozygote or homozygote mutant carriers gene 3 gene, i.e., MTHFR1298AA and RFC180GG (both genes with wild alleles as reference group) compared with 1298AC/ CC or 80GA/AA (mutation in only one gene) compared with 1298AC/CC and 80GA/AA (both genes presenting a mutant allele). However, case and control group distribution did not significantly differ. Although observational studies are considered a standard design for genetic association investigation, these studies are prone to spurious allelic association-named population stratification (46) . This occurs when cases and controls have different allelic frequencies related to the diversity in background population and not related to the outcome (46) . To avoid misinterpretation, adjusting for race/ethnicity is recommended (46) . Therefore, it is possible that residual confounding could bias our results. However, we conducted an additional analysis considering only non-white participants and the results were similar. Another limitation of this study might be related to variations in intakes of folate with the mandatory fortification of wheat and corn flour established during the period of data collection, in July 2004. However, case and control groups were recruited in the same period and we think that both groups were equally exposed and the effect on the estimated risk was similar in all study groups. The frequency of homozygosis for the mutant allele among white participants was similar to previous studies (47, 48) . We observed an association between CIN1 and MTHFR C677T and RFC1 G80A; increased risk alleles were the wild allele for both genes. For CIN2+, associated genes were MTHFR C677T, A1298C, and MTR A2756G; the risk allele was wild for A1298C and mutant for A2756G. In previous studies, an association between MTHFR and cervical dysplasia risk was null among Americans, Indians, Koreans, and Greeks (23,49-51) but positive for 677TT among Hawaiians (8) . The mutant allele, TT, was protective for cervical cancer among Europeans and white women in meta-analyses including case-control studies (52) (53) (54) . For MTHFR A1298C, the presence of a polymorphism was marginally and positively associated with cervical dysplasia (55) . The opposite effect was observed among Korean women (23) . The inconsistency of the association of the MTHFR polymorphism was observed for epithelial and glandular neoplasia (56, 57) . It seems that the MTHFR677 polymorphism appears to modify risk of cancer in a site-specific mode, reducing for colorectal cancer and increasing for breast cancer (58), or may be race specific.
Dietary intake of total folate was extremely low in the present study. This is expected in a population with poor diet diversity with low vegetables intake that is not exposed to folic acid-enriched cereal and supplements. Our study population median total folate intake was ;250 mg/d, equivalent to the lowest group of folate intake in studies conducted before mandatory folic acid food fortification programs (8, (10) (11) (12) 22) . In these studies, protection against cervical dysplasia was observed among women with folate intake >400 mg/d, but not among supplement users (8, 9, 59 ).
Although folate intake was similar between study groups, the serum folate concentration increased according to severity from CIN1 to CIN3. Studies conducted in the United States showed higher folate concentrations among controls and an increase in folate concentrations across dysplasia severity in the nonfortification period (18, 22, (60) (61) (62) . However, 2 United States studies and 1 Korean study observed lower concentrations among highest dysplasia (16, 20, 23) . In a prospective study, red blood folate was negatively associated with becoming infected with high-risk HPV and, when infected, a greater likelihood for clearance and lower risk of CIN2+ (63) . In the NHANES III and mortality file, baseline serum folate status ranging from 6.8 to >21.3 nmol/L was associated with all-cancer mortality in a bell-shaped risk, with 40% increased risk among participants with serum folate between 12 and 18 nmol/L (59). A possible biological plausibility for increased concentrations of serum folate through the stages of precancerous neoplastic lesions is the reduced expression of the folate receptor in cervical dysplasia cells, observed in varying grades of cervical dysplasia compared with normal cervical tissue, which impairs the methylation of cervical cell DNA (62) . A significant increase of hypomethylation in cervical cancer cells was observed compared with precancerous lesions and controls (59, 62) . Evaluation of possible effects of folate is complicated by methodological issues, such as different intake according to population exposed or not to mandatory folic acid fortification or lack of total energy adjustment. However, a U-shaped risk of cancer according to dietary intake has been observed, increasing the risk above an upper tolerable limit of 1 mg/d of folic acid as well as a bell-shaped risk of cancer for circulating folate (63, 64) .
The present study suggests that the frequency of polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating nutrients with cervical neoplasia. Our data strengthen the importance of an adequate intake of both folate and vitamin B-6 in a developing country not covered by HPV vaccine from the public health immunization program in addition to other prevention strategies. We think that our results can be beneficial in resource-poor settings to strengthen the importance of a healthy diet to prevent against cervical dysplasia.
